About the Fund
The Dean R. O'Neill Renal Cell Cancer Research Fund works in partnership with the Foundation for the National Institutes of Health (FNIH), National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) to search for a cure for renal cell cancer. Commonly referred to as kidney cancer, renal cell carcinoma is an under-researched and growing disease, with over 50,000 cases diagnosed each year.
The Fund sponsors a dedicated research program at NIH to explore new and existing treatments, such as allogeneic stem cell transplantation, chemotherapy, radiation therapy, immunotherapy, vaccine therapy, and drug treatments. The program supports the Dean R. O'Neill post-doctoral fellow, who works in conjunction with the laboratory of Dr. Richard Childs and the NHLBI. The Fund is a donor-advised program under the Foundation for the National Institutes of Health (FNIH), which is a 501(c)(3) non-profit charitable organization.
To learn more about the Fund, please visit the fund website: www.renalcellcancer.org
The Foundation for the National Institutes of Health procures funding and manages alliances with public and private institutions and individuals in support of the mission of the NIH, the premier medical research agency. The Foundation, also known as the FNIH, works with its partners to accelerate biomedical research and strategies to fight against diseases in the United states and across the world.
The FNIH organizes and administers research projects; supports education and training of new researchers; organized educational events and symposia; and administers a series of funds, such as the Dean R. O’Neill Renal Cell Cancer Research Fund, supporting a wide range of health issues.
Established by Congress in 1996, the FNIH is a not-for-profit 501 (c)(3) charitable organization. For additional information about the FNIH please visit www.fnih.org
To view the Dean R. O'Neill page at FNIH, click here.